SV

Shraddha Vinayak Dhamankar

Active Director Director DIN 00553157
DIN 00553157 First appointment Jan 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 1 historical roles
Total affiliations 10 Since Jan 2001
Shareholding value •••• Premium profile

About Shraddha Vinayak Dhamankar

Data last updated:

Shraddha Vinayak Dhamankar is a Director at Enem Nostrum Remedies Private Limited (since 2001), Director at Thurs Organics Private Limited (since 2009) and Director at Nli Healthcare (India) Private Limited (since 2019), and holds 6 more current directorships. The companies operate in Pharma, Chemicals and Materials and Information Technology. The 9 current companies with reported revenue have a combined latest revenue of ₹64.52 Cr; the largest is Enem Nostrum Remedies Private Limited at ₹42.33 Cr (FY 2025). Earlier, Shraddha Vinayak Dhamankar was a Director at Vidit Pharma Sciences Private Limited (from 2022).

DIN 00553157
Primary Designation Director
Industry Pharma
First Appointment 01 Jan 2001
Oldest Company Age 29 yrs
Largest company Enem Nostrum Remedies Private Limited · ₹42.33 Cr (FY 2025)
Combined revenue ₹64.52 Cr across 9 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jan 20012001₹42.33 Cr (FY 2025)Active
Thurs Organics Private Limited U24116MH1997PTC106693
Director30 Nov 20091997₹21.47 Cr (FY 2024)Active
Director15 Feb 20192019₹58.9 Lakh (FY 2024)Active
Nexgen Healthcare Private Limited U24230MH2004PTC148417
Director06 Sep 20042004₹6.3 Lakh (FY 2025)Active
Symmetrix Biotech Private Limited U24239MH2007PTC167239
Director24 Jan 20072007₹5.5 Lakh (FY 2025)Active
Director14 Dec 20112011₹35,170 (FY 2023)Active
Nostrum Technologies Private Limited U72900MH2007PTC173481
Director27 Aug 20072007₹21,450 (FY 2022)Active
Director01 Jan 20202000₹20,120 (FY 2022)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jan 20222022Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Thurs Organics Private Limited
Enem Nostrum Remedies Private Limited
Nexgen Healthcare Private Limited
Symmetrix Biotech Private Limited
Premium access

Shareholding and investment profile for Shraddha Vinayak Dhamankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shraddha Vinayak Dhamankar

Shraddha Vinayak Dhamankar currently holds 9 directorships: Enem Nostrum Remedies Private Limited (Director, since 01 Jan 2001, revenue ₹42.33 Cr (FY 2025)); Thurs Organics Private Limited (Director, since 30 Nov 2009, revenue ₹21.47 Cr (FY 2024)); Nli Healthcare (India) Private Limited (Director, since 15 Feb 2019, revenue ₹58.9 Lakh (FY 2024)); Nexgen Healthcare Private Limited (Director, since 06 Sep 2004, revenue ₹6.3 Lakh (FY 2025)); Symmetrix Biotech Private Limited (Director, since 24 Jan 2007, revenue ₹5.5 Lakh (FY 2025)); and 4 more.

Shraddha Vinayak Dhamankar was first appointed on 01 Jan 2001 as Director at Enem Nostrum Remedies Private Limited. The most recent appointment on record is 21 Jan 2022 at Vidit Pharma Sciences Private Limited.

The 9 current companies of Shraddha Vinayak Dhamankar that report revenue have a combined latest revenue of ₹64.52 Cr: Enem Nostrum Remedies Private Limited ₹42.33 Cr (FY 2025); Thurs Organics Private Limited ₹21.47 Cr (FY 2024); Nli Healthcare (India) Private Limited ₹58.9 Lakh (FY 2024); Nexgen Healthcare Private Limited ₹6.3 Lakh (FY 2025); Symmetrix Biotech Private Limited ₹5.5 Lakh (FY 2025); and 4 more.

Shraddha Vinayak Dhamankar held 1 earlier board appointment: Vidit Pharma Sciences Private Limited (Director, from 21 Jan 2022).

The current boards of Shraddha Vinayak Dhamankar's companies include Anilkumar Shridhar Mulye (Enem Nostrum Remedies Private Limited), Vinayak Atmaram Dhamankar (Thurs Organics Private Limited), Kaushik Krishnakant Vyas (Symmetrix Biotech Private Limited), Rama Ravikiran Marathe (Symmetrix Biotech Private Limited), Yatindra Prashar (Symmetrix Biotech Private Limited), Nirmal Vasant Mulye (Bombay Bio-Research Centre Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available